C3 glomerulopathy (C3G) and immune-complex membranoproliferative glomerulonephritis (IC-MPGN) are two diseases that have a ...

Company officials say they are focusing on "more disciplined managed products" as they prepare to exit PPOs in 2026 that currently cover 800,000 members, including 600,000 people enrolled in Medicare ...

An expert discusses how home administration of oncology drugs in the US faces significant logistical and reimbursement ...

Sarepta continues to work with regulators to complete the safety label update for Elevidys, and they are discussing an approach for risk mitigation for non-ambulatory patients.

In a press release in advance of an 8 a.m. earnings call, the company said that the second-quarter consolidated medical-care ratio of 89.4% increased 430 basis points year-over-year. The increase was ...

Medicare Advantage enrollment transforms post-acute care, impacting home health, hospice and skilled nursing services amid evolving value-based care challenges.